No effect of menstrual cycle phase on basal very-low-density lipoprotein triglyceride and apolipoprotein B-100 kinetics.
Dyslipidemia, manifested by increased plasma triglyceride (TG), increased total and LDL-cholesterol concentrations and decreased HDL-cholesterol concentration, is an important risk factor for cardiovascular disease. Premenopausal women have a less atherogenic plasma lipid profile and a lower risk of cardiovascular disease than men, but this female advantage disappears after menopause. This suggests that female sex steroids affect lipoprotein metabolism. The impact of variations in the availability of ovarian hormones during the menstrual cycle on lipoprotein metabolism is not known. We therefore investigated whether very-low-density lipoprotein (VLDL)-TG and VLDL-apolipoprotein B-100 (apoB-100) kinetics are different during the follicular (FP) and luteal phases (LP) of the menstrual cycle. We studied seven healthy, premenopausal women (age 27 +/- 2 yr, BMI 25 +/- 2 kg/m(2)) once during FP and once during LP. We measured VLDL-TG, VLDL-apoB-100, and plasma free fatty acid (FFA) kinetics by using stable isotope-labeled tracers, VLDL subclass profile by nuclear magnetic resonance spectroscopy, whole body fat oxidation by indirect calorimetry, and the plasma concentrations of lipoprotein lipase (LPL) and hepatic lipase (HL) by ELISA. VLDL-TG and VLDL-apoB-100 concentrations in plasma, VLDL-TG and VLDL-apoB-100 secretion rates and mean residence times, VLDL subclass distribution, FFA concentration and rate of appearance in plasma, whole body substrate oxidation, and LPL and HL concentrations in plasma were not different during the FP and the LP. We conclude that VLDL-TG and VLDL-apoB-100 metabolism is not affected by menstrual cycle phase.
Magkos
Faidon
F
Washington University School of Medicine, St. Louis, MO 63110, USA.
Patterson
Bruce W
BW
Mittendorfer
Bettina
B
D000328:Adult; D053299:Apolipoprotein B-100 / Q000097:blood*; D002153:Calorimetry, Indirect; D004797:Enzyme-Linked Immunosorbent Assay; D004958:Estradiol / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D005498:Follicular Phase / Q000097:blood; D005990:Glycerol / Q000097:blood; D006801:Humans; D007700:Kinetics; D007930:Leucine / Q000097:blood; D008049:Lipase / Q000097:blood / Q000378:metabolism; D008079:Lipoproteins, VLDL / Q000097:blood*; D008099:Liver / Q000201:enzymology; D008183:Luteal Phase / Q000097:blood; D009682:Magnetic Resonance Spectroscopy; D008597:Menstrual Cycle / Q000502:physiology*; D010168:Palmitates / Q000097:blood; D010316:Particle Size; D011374:Progesterone / Q000097:blood; D014280:Triglycerides / Q000097:blood*
D053299:Apolipoprotein B-100; D005230:Fatty Acids, Nonesterified; D008079:Lipoproteins, VLDL; D010168:Palmitates; D014280:Triglycerides; D011374:Progesterone; D004958:Estradiol; D008049:Lipase; D007930:Leucine; D005990:Glycerol